Acta Anaesthesiol Scand 1993: 37: 38-44

Influence of high thoracic epidural anesthesia on left ventricular contractility assessed using the
end-systolic pressure-length relationship
A. W. GOERTZW, . SEELINGH, . HEINRICHK, . H . LINDNERand U. SCHIRMER
Department of Anesthesia, University of Ulm Medical Center, Federal Republic of Germany
The effect of high thoracic epidural anesthesia (TEA) on left ventricular contractility was studied in a prospective clinical trial. Forty-eight patients with ASA physical status 1 and 2 and without cardiovascular disease were included in the study. Thirty-six patients scheduled for elective upper abdominal surgery were randomly assigned to Group 1 (TEA, bupivacaine 0.25%, n = 12), Group 2 (TEA, bupivacaine 0.5"/0,n = 12) or to Group 3 (control without TEA, n = 12). TEA induced a sensory block which extended over all cardiac segments. In order to assess the effect of systemically absorbed bupivacaine, we studied a separate group of patients who received lumbar epidural anesthesia without involvement of the cardiac segments: Group 4 (LEA, bupivacaine 0.5%, n = 10). Left ventricular contractility was assessed using the end-systolic pressure-length relationship. Left ventricular dimensions were measured by transesophageal echocardiography. All hemodynamic measurements were performed under general anesthesia. There was no significant difference in systolic or diastolic arterial pressure, heart rate, left ventricular end-systolic and end-diastolic cross-sectional areas and left ventricular wall stress between the four groups. Left ventricular maximum elastance as a measure of left ventricular contractility was significantly ( P < 0 . 0 0 1 ) reduced in Groups 1 and 2 [8.1 ( k 3.5) and 9.6 ( k 4.4) k P a . c m - ' , respectively] as compared to Groups 3 and 4 [18.4 ( f8.8) and 17.7 (k7.7) k P a . c m - ' , respectively]. No significant difference could be demonstrated between Groups I and 2 or between Groups 3 and 4.It is concluded that high TEA severely alters left ventricular contractility even in subjects without pre-existing cardiac disease.
Received 21 December 1991, accepted for publication 25 May 1992
Key words: Anesthetic techniques, epidural; heart, contractility, echocardiography; sympathetic nervous system, blockade.

High thoracic epidural anesthesia (TEA) has recently been proposed for therapeutic use in patients with coronary artery disease (1-4). The use of high TEA in this group of patients raises the question whether this technique has an effect on global left ventricular function. Although this has been the subject of several experimental (5-7) and clinical studies (8-12), there is still controversy about the effect of high thoracic epidural block on left ventricular contractility, which is variously reported to be unaltered (5, 12), reduced (6-8, 10, 11) or even improved ( 3 , 4, 9). Besides differences in study design or population, one reason for these discrepancies may be the varying extent of vasomotor blockade leading to different cardiac loading conditions. As a measure of ventricular performance isovolumetric and ejection phase indices like dp/dt,,, (5-7, 9), stroke volume (10, 12), systolic time intervals ( 1 1 ) or ejection fractions (4) have been used. All these parameters are known to be highly dependent on cardiac loading conditions ( 13).
At present, there is no report on the assessment of

left ventricular contractility under high TEA using the end-systolic pressure-volume (or -length) relationship (ESPVR and ESPLR, respectively), which is believed to be relatively insensitive to alterations in cardiac loading ( 14). The aim of the current investigation was to assess left ventricular contractility in subjects with normal left ventricular function using ESPLR. Since bupivacaine is commonly used in either 0.5% or 0.25% concentration, both concentrations were used in our study in separate groups. I n order to consider the systemic action of absorbed bupivacaine, we included a group of patients receiving lumbar epidural anesthesia (LEA) without involvement of cardiac segments.
MATERIAL AND METHODS
Patients After approval by the ethics committee of our university and informed written consent, 48 patients (ASA physical status 1 or 2) of either sex were included in the study. All patients were scheduled for elective

LV CONTRACTILITY W I T H EPIDURAL ANESTHESIA

39

abdominal surgery: duodenum-preserving resection of the pancreatic head ( n = 18), cholecystectomy ( n = 6 ) , cholecystojejunostomy ( n = 3), liver tumor resection ( n = 2 ) , Whipple's pancreaticoduodenecto-
my ( n = 3j, resection ofthe sigmoid ( n = 7 ) , cholecystectomy + neph-
rectomy ( n = I j, hemicolectomy ( n = 3 ) , partial resection of the pan-
creas ( n = 3 ) and cystojejunostomy of a pancreas cyst ( n = 2 ) . Exclusion criteria were any kind of cardiocirculatory disorder, contraindications against epidural anesthesia and contraindications against transesophageal echocardiography such as gastric or esophageal pathology. Two of the 48 subjects were excluded during the course of the trial because the echocardiographic recordings were of insufficient quality.
Thirty-six of the patients scheduled for upper abdominal surgery werr randomly assigned to Group I (TEA with bupivacaine 0.25%,, n = 12), Group 2 (TEA with bupivacaine 0.5%, n = 12) or Group 3 (control group without epidural anesthesia, n = 12). Another ten patients scheduled for lower abdominal surgery were assigned to Group 4 (LEA with bupivacaine 0.5'1/0). The assignment to Group 4 was not done at random since the epidural catheter of patients participating in our study was used for postoperative analgesia and we found it unethical to provide patients scheduled for lower abdominal surgery with thoracic catheters and vice uersa. Demographic data are presented in Table I.
Experimental protocol
The patients of Groups I , 2 and 4 received their epidural catheter on the evening before surgery. The epidural space was punctured using the loss-of-resistance technique and the median approach. The site of insertion was the mid to lower thoracic region (Groups 1 and 2) and the lumbar region (Group 3), respectively.
All measurements were performed on the day of the operation under general anesthesia and prior to surgery. All patients were premedicated with dipotassium clorazepate 20 mg p.0. given 2 h prior to the measurements. O n arrival in the operating theatre, intravenous cannulas, a radial artery catheter and ECG leads were placed. Epidural anesthesia was established giving increments of 3 to 5 ml of plain bupivacaine 0.25% (Group I ) and 0.5% (Groups 2 and 4), respectively, until the extension of the block, evaluated by pin-prick, exceeded the cardiac segments (Groups 1 and 2). Data about the puncture site, the extension of the block, the dosage and volume of bupivacaine are presented in Table I .
' During administration of the local anesthetic 10 ml .kg- of a 6%
hydroxyethyl starch solution was infused in order to compensate for peripheral vasodilation. This volume augmentation was not performed in the control group. Once the desired extent of the block was established, general anesthesia was induced using midazolam (0.1 mg. kg-l) and fentanyl (5 p g ' k g - l ) . Neuromuscular blockade was performed with vecuronium (0.1 m g - k g - ' ) . T h e trachea was intubated and respiration controlled by intermittent positive pressure ventilation. T h e respiratory rate was 10 m i d , using 40% oxygen in nitrous oxide. Tidal volume, and thereby minute volume, was adjusted to produce normocapnea (P,co, 4.6-6.0 kPa, Capnometer Hewlett-Packard@j.T h e measurements started 10 min after the induction of general anesthesia with the patient in a supine position and without any surgical stimulation.
Hemo4namic measurements and calculations
The transesophageal echocardiographic registrations were performed using a 3400R Varian'" with a 3.5 MHz transducer (DiasonicsB Inc., Milpitas, CA, USA). The esophageal probe was advanced to a position where left ventricular cross-sectional registrations at midpapillary muscle level could be obtained (15). Real-time two dimensional as well as M-mode registrations were recorded on videotape together with the arterial pressure curve, E C C and capnographic curve.
The following parameters were measured on the echocardiogra-

phic recordings: left ventricular end-systolic and end-diastolic crosssectional area (LVESA and LVEDA, respectively), left ventricular end-systolic and end-diastolic diameter (LVESD and LVEDD, respectively) and left ventricular end-systolic and end-diastolic wall thickness (LVSWT and LVDWT, respectively), For calculating ESPLR, the systolic arterial pressurc- (SAP) was transiently decreased by central venous bolus injections of nitroglycerine (NTG). I n order to induce a drop of systolic pressure of 20-25 mmHg (2.7-3.3 kPa), we administered a NTG bolus dose of 0.5-1 pg . kg- I.
All data were analyzed ollline using an electronic evaluation device (Cardio 200"9, Kontron Instruments GmbH, Stuttgard, F R G ) . The measurements were restricted to the expiratory phase of the respiratory cycle. The endocardial and pericardial line were identified according to the leading edge method (16). End-diastole was indicated by the peak of the R-wave. End-systole was defined as the smallest systolic endocardial area and diameter, respectively. The observers analyzing the echocardiographic data were blinded to the group. Interobserver variability was assessed prior to a series of investigations and has been reported in a n earlier publication ( 1 7).
The following parameters were calculated from the data measured: Fractional area change (FAC) = (LVEDA- LVESA)/LVEDA 100%
(18).
End-systolic wall stress (ESWS) = 0.334 SAP LVESD/LVSWT ( 1 +
LVSWT/LVESD) lo3 dyn cm-* (19). According to Thys and coworkers (20), we calculated peak systolic
wall stress by including the diastolic ventricular dimensions in the original equation, assuming that no significant changes occur in these dimensions between end-diastole and the time at which peak systolic wall stress is developed: Peak-systolic wall stress (PSWS) = 0.334 SAP LVEDD/
LVDWT(I + I,VDWT/LVEDD) 10" dyn cm-'
The inotropic state of the left ventricle was assessed using the maximal elastance (E,,,) of the end-systolic pressure-length relationship according to the method described by Suga and Sagawa ( 21-23). During the nitroglycerine-induced decrease in arterial pressure, endsystolic pressureiend-systolic diameter values were obtained and subjected to linear regression analysis. Only those values were included that were measured before any change in heart rate occurred as a result of decreasing arterial pressure.
Statistical anahsis
All numerical data about the patients' characteristics and extradural anesthesia as well as the hemodynamic data were analyzed using analysis of variance (ANOVA), followed by Scheffi's test. All data
+ are given as arithmetic means ( s.d.) with the exception of data on
the extent of the sensory block and the puncture site that are presented as median (range). Statistical significance was assumed with P<0.05.
RESULTS
The four groups were comparable with respect to their age, height, weight and body surface area. The extent of the sensory block was equal in Groups 1 and 2. In all patients receiving TEA, the sensory block exceeded Th, and thus completely covered the cardiac segments. There was no significant difference in the amount of bupivacaine given in Groups 2 and 4. As expected, the bupivacaine dose was lower in Group 1 compared
to Groups 2 and 4 (Table 1 ) . All hemodynamic data are summarized in Table 2.
Systolic, diastolic and thus also mean arterial pressure were not significantly altered during either thoracic or

Table 1
Demographic and anesthetic data. Age, height, weight and body surface area (BSA) are given as arithmetic means ( f s.d.). The data about epidural anesthesia include volume and dose of administered bupivacaine, given as mean ( 2 s.d.), the segmental location of the puncture site and the upper and lower level of sensory block presented as median {range}.

Epidural anesthesia

Sensory block

Bupivacaine

Group 1

Age (years) 54 ( I t 12)

Height (cm)
169 ( f 12)

TEA bupivacaine 0.25% n = 12

Group 2 TEA bupivacaine 0.5% n = 12
Group 3 control n = 12

49 ( f 10)

172 (f7)

44 ( i14)

168 ( i 8 )

Group 4

50 ( i 7 )

167 (i6)

LEA bupivacaine 0.5% n = 10

*** indicates P < O . O O I compared to Group 2 and 4.

Weight (kg)
70 ( f 19)

BSA (m2) 1.79 ( f 0.27)

Puncture site (segm.) ThW
{Th,,,-Th10,1 I}

Upper level (segm.1 Th I {C,-Th,}

Lower level (segm.) L3
{Thi,-L,)

69 (f10)

1.80 (20.14)

Th9iIO

{Th,,8-Thl,l 11

Th 1 {C,-ThJ

65 ( i 8 )

1.73 (20.13)

----

____

L* {Thli-L3}
____

71 ( & 18) 1.77 ( i 0 . 2 3 )

L3/+ {L2j3-L4i5}

Thl, fT$-L, }

s,
{L5-S5}

Volume

Dosis

(ml)

(mg)

19.7 ( f 4 . 0 ) 49.1 (i10.1)*** ?
2

0

17.7 ( i 3 . 5 ) 88.7 (k 17.7)

a F;i

2

____

---_

3 r

18.6 ( ~4t.6) 93.0 ( 22.9)

Table 2
Hemodynamic data. Systolic, diastolic and mean arterial pressure (SAP, DAP and MAP, respectively), heart rate (HR), end-diastolic and end-systolic left ventricular area (EDA and ESA, respectively), fractional area change (FAC), end-systolic and peak-systolic wall stress (ESWS and PSWS, respectively) and the maximal elastance of the left ventricle (E,,,(ESPLR) of the four groups. All data are given as arithmetic means ( s.d.).

Group 1 TEA bupivacaine 0.25% n = 12
Group 2 TEA bupivacaine 0.5% n = 12
Group 3 control

SAP

DAP

MAP

HR

EDA

ESA

FAC

(mmHg)

(mmHg)

(mmHg)

(min-')

(4 (cm')

ikPal

ikPa)

ikPa)

ESWS

PSWS

(lo' dynes cm-')

E,,,(ESPLR) (mmHg mm-')
lkPa cm-?

111 ( f 1 5 ) 6 3 ( f 1 0 ) 7 9 ( f I O ) 6 4 ( f 1 3 ) 21.1 ( k 6 . 7 ) g . g ( f 4 . 3 ) 5 4 ( f 9 ) 60.1 ( f 1 8 . 5 ) 131.7(+22.2) 14.8 ( f 2.0) 8.4 ( f 1.3) 10.5 ( f 1.3)

6.1 (+2.6)*** 8.1 ( f 3 . 5 )

113 (f14) 64 ( + 9 )

80 ( f 10) 65 ( f 10)

15.1 ( f1.9) 8.5 ( f 1.2) 10.7 ( f 1.3)

22.2 (6.2) 9.7 ( f 2.8) 56 (f6) 49.3 ( f 10.0) 116.7 ( f 38.3)

7.2 ( f 3.3)*** 9.6 ( f 4.4)

s
X

115 ( f 1 2 ) 65 ( f 6 )

82 ( f 7)

77 ( ? 13) 20.2 ( f 5.2) 9.7 ( f 3.0) 53 (f6) 58.6 ( ?r 19.0) 133.5 ( f 45.5)

15.3 (f1.6) 8.7 ( f 0 . 8 ) 10.9 ( 50.9)

13.8 ( f 6.6) 18.4 (f8.8)

n = 12

Group 4
LEA bupivacaine 0.5% n = 10

113 ( f 13) 66 ( f 9 )

81 ( f 10) 62 ( f 12) 20.6 ( f 6 . l )

15.1 (f1.7) 8.8 ( f 1.2) 10.8 ( k 1.3)

*** indicates P<O.OOl compared to Group 3 (control) and compared to Group 4 (LEA).

9.7 ( f 2 . 9 )

54 ( f 6 )

63.2 ( f 12.7) 135.7 ( f 2 3 . 7 )

13.3 ( f 5 . 8 ) 17.7 (f7.7)

42

A. W. GOERTZ ET AL.

lumbar epidural anesthesia. The heart rate tended to be somewhat lower during thoracic and lumbar epidural anesthesia as compared to the control group; however, the level of significance was not reached. Left ventricular end-diastolic and end-systolic areas were similar in all four groups, leading to comparable values for the fractional area change. No significant difference could be demonstrated between the values for endsystolic and peak-systolic wall stress calculated in the four groups. Left ventricular contractility, measured as maximal elastance (Emax)of the ESPLR, was approximately halved during thoracic epidural anesthesia, without any difference between the two bupivacaine concentrations. This reduction was highly significant in comparison to the control and the lumbar
epidural group ( P =0.0002). There was no difference
in the Em,, value between Groups 3 and 4 (Fig. 1 ) . No complications resulted from the study, and in
all patients receiving epidural anesthesia the epidural catheter was used intraoperatively in combination with general anesthesia, and also provided the route for postoperative analgesia.
DISCUSSION The major finding of this study was that left ventricular contractility, measured as the maximal elastance of the left ventricle, was grossly reduced during high thoracic epidural anesthesia, but that this did not occur when the same amount of bupivacaine was injected into the lumbar epidural space. This negative inotropic effect was not dependent on the concentration of bupivacaine administered, indicating that a similar degree of sympathetic blockade was achieved with bupivacaine
group 1 ~ E A ) group2 (TEA) group 3 (control) group 4 (LEA) Fig. 1. Arithmetic means ( k s.d.) of the maximal elastance (Emaxo)f the left ventricle. ***indicates P i 0.001 versus Group 3 (control) and versus Group 4 (lumbar epidural anesthesia).

0.25% and bupivacaine 0.5%. The patients receiving either thoracic or lumbar epidural anesthesia showed a remarkable degree of hemodynamic stability, with no alteration in systolic or diastolic arterial pressure and only insignificant cardiac slowing. The indices of left ventricular preload were not reduced with either form of epidural anesthesia. Without performing intravascular volume expansion (as was done in the epidural groups), we might have seen a reduction in left ventricular preload as a result of peripheral vasodilation and reduced systemic venous return (24, 25), in spite of some compensatory vasoconstriction that may have occurred in segments not affected by the block (9, 25, 26).
Surprisingly, left ventricular afterload measured as end-systolic and peak-systolic wall stress was not significantly affected by lumbar or thoracic epidural anesthesia. We are not aware of any study using wall stress as a measure of left ventricular afterload in subjects receiving epidural anesthesia. However, one must keep in mind that the true invasively measured peak systolic wall stress occurs towards the end of the first third of systole and is probably overestimated in our approximation of peak-systolic wall stress (27). This uncertainty must be considered when interpreting the effect of epidural block on FAC which appeared not to be altered by either TEA or LEA. I n face of a n unchanged pre- and afterload and a reduced contractility, a constant FAC is difficult to interpret and may require the inclusion of systolic time indices which were not measured in our study.
An improvement in left ventricular performance during high thoracic epidural anesthesia has been reported by two groups (3, 4, 9). Kock and coworkers found an improvement in left ventricular global and regional function during stress-induced myocardial ischemia in patients with coronary artery disease under TEA plus P-blocker compared to the same patients under P-blocker alone (4). It is remarkable that they did not find any effect ofhigh TEA on central hemodynamics, when applied to patients treated with P-blockers and without ischemic attack (3). It is difficult to compare the experimental setting and study population of their study to that of our investigation, but since the mean systolic pressure measured during exercise was reduced from 197 to 160 mmHg (26.3 and 2 1.3 kPa, respectively) under TEA, one may speculate that the increased ejection fraction seen with TEA might, at least in part, have been the result of a reduced left ventricular afterload. Bonica and coworkers studied the hemodynamic effects of different levels of epidural anesthesia in healthy volunteers (9). They reported the unexpected results of an increase in cardiac output when they extended the block over the

LV CONTRACTILITY W I T H EPIDURAL ANESTHESIA

43

cardiac segments. They speculated that this might have been the result of a stimulating effect of absorbed lidocaine on the cardiovascular system, due either to central nervous stimulation or to potentiation of endogenous catecholamines.
The reduction in left ventricular contractility found in our study during TEA could have been caused by two separate mechanisms. Firstly by the blockade of cardiac sympathetic fibers and secondly by the systemic action of absorbed local anesthetic. The effect of absorbed local anesthetic on ventricular inotropic state is twofold. It is well known that bupivacaine may have a direct depressant effect on the myocardium ( 1 1 ) . O n the other hand, it potentially elicits some stimulating effects on the circulation, most likely via central activation (9, 28, 29). I n order to consider the effect of absorbed local anesthetic we included a group who received a dose of bupivacaine equal to that of the Group 2 patients into the lumbar epidural space. I n both groups, plasma concentrations of local anaesthetic would be expected to be comparable (30). The upper level of the sensory block in the LEA group ranged from Th, to L,. So it is unlikely that the block induced by LEA involved the cardiac segments (26). We therefore conclude that the negative inotropic effects seen with high thoracic epidural anesthesia in our study are mainly due to sympathetic denervation of the heart. This denervation is evident even at the lower concentration of bupivacaine.
We used the slope (Emaxo)f the end-systolic pressure length relationship (ESPLR) as a measure of left ventricular contractility since it is believed to be relatively insensitive to left ventricular loading conditions ( 14, 2 1-23). This load independency represents the major advantage over the traditional ejection phase and isovolumetric phase indices of contractility (13). There have been several studies on intact animals (31, 32) and on humans (33-35) that confirmed the initial results from Suga and Sagava (14, 21-23). However, the concept of Em,, as a measure of left ventricular contractility has recently been the subject of some criticism (36, 37). Crottogini and coworkers proposed a new index combining the changes of Em,, and of the volume axis intercept: the area beneath the ESPVRline between defined volume limits (36).However, this method (i.e. the definition of volume- or diameterlimits) has not yet been validated for interindividual comparisons, so that it did not appear applicable in our experimental setting.
In this study we chose to use transesophageal echocardiography (TEE) to determine left ventricular dimensions because it is superior to external echocardiography with respect to the quality and reproducibility of the recordings (38). Performing TEE on

conscious patients is unpleasant and might cause adrenergic as well as vagal reactions. We therefore performed our measurements under general anesthesia. That may well have lowered the baseline levels of heart rate and arterial pressure, and may thereby have influenced other derived parameters.
Individual cardiovascular response to different levels of sympathetic blockade varies widely, depending on the degree of sympathetic tone prior to the block (9). Obviously, even in healthy subjects under general anesthesia and without any surgical stimulation, a relevant degree of sympathetic influence on the heart seems to be present, the blockade of which leads to significant alteration in ventricular performance. Using high TEA in patients with impaired global ventricular function and increased sympathetic tone could therefore have deleterious effects.
In summary, we found left ventricular contractility to be grossly reduced with high thoracic epidural anesthesia. Since this negative inotropic effect could not be demonstrated with the same dose of bupivacaine when administered into the lumbar epidural space, it is likely that this reduction in contractility is mainly the result of sympathetic denervation of the heart. Whether these results are valid for patients with compromised ventricular function and how P-blocker therapy alters the effects of epidural block in these patients remain to be investigated.
REFERENCES
1. Toft P, Jorgensen A. Continuous thoracic epidural analgesia for the control of pain in myocardial infarction. Intensive Care Med 1987: 13: 388-389.
2. Blomberg S, Emanuelsson H, Ricksten S-E. Thoracid epidural anesthesia and central hemodynamics in patients with unstable angina pectoris. Anesth Analg 1989: 69: 558-562.
3. Blomberg S, Emanuelsson H, Kvist H et al. Effects of thoracic epidural anesthesia on coronary arteries and arterioles in patients with coronary artery disease. Anestheszolog, 1990: 73: 840-847.
4. Kock M, Blomberg S, Emanuelsson H, Lomsky M, Stromblad S-0, Ricksten S-E. Thoracic epidural anesthesia improves global and regional left ventricular function during stress-induced myocardial ischemia in patients with coronary artery disease. Anesth Analg 1990: 71: 625-630.
5. Ottesen S, Renck H, Jynge P. Cardiovascular effects of epidural analgesia. I. Thoracic epidural analgesia. Acta Anaesthesiol Scand 1978: 69(Suppl): 1-16.
6. Hotvedt R, Refsum H, Platou E S. Cardiac electrophysiological and hemodynamic effects of P-adrenoceptor blockade and thoracic epidural analgesia in the dog. Anesth A n d g 1984: 63: 8 17-824.
7. Davies R F, Deboer L W V, Maroko P R. Thoracic epidural anesthesia reduces myocardial infarct size after coronary artery occlusion in dogs. Anesth Analg 1986: 65: 711-717.
8. Otton P E, Wilson E J. The cardiocirculatory effects of upper thoracic epidural analgesia. Can Anaeslh S O C J1966: 13: 541-549.
9. Bonica J J, Berges P U, Marikawa K. Circulatory effects of

44

A. W. GOERTZ ET AL.

peridural block: I. Effects of level of analgesia and dose of lidocaine. Anesthesiology 1970: 33: 619-626. 10. LundbergJ, Norgren L, Thomson D, Werner 0.Hemodynamic effects of dopamine during thoracic epidural analgesia in man. Anesthesiology 1987: 66: 641-646. 11. Wattwil M, Sundberg A, Arvill A, Lennquist C. Circulatory changes during high thoracic epidural anaesthesia - influence of sympathetic block and of systemic effect of the local anaesthetic. Acta Anaesthesiol Scand 1985: 29: 849-855. 12. Tanaka K, Harada T. Low-dose thoracic epidural anesthesia induces discrete thoracic analgesia without reduction in cardiac output (abstract). Anesthesiology 1990: 73 (suppl):A127. 13. Robotham J L, Takata M, Berman M, Harasawa Y. Ejection fraction revisited. Anesthesiology 1991: 74: 172-183. 14. Suga H, Sagawa K, Shoukas A A. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate ratio. Circ Res 1973: 32: 314-322. 15. Schluter M, Hinrichs A, Thier W et al. Transesophageal two dimensional echocardiography: comparison of ultrasonic and anatomic sections. A m J Cardiol 1984: 53: 1173-1 178. 16. Wyatt H L, Haenddchen R V, Meerbaum S, Corday E. Assessment of quantitative methods for 2-dimensional echocardiography. A m J Cardiol 1983: 52: 396-401. 17. Goertz A, Heinrich H, Winter H, Deller. Hemodynamic effects of different ventilatory patterns. A prospective clinical trial. Chest 1991: 99: 1166-1171. 18. Abel M D, Nishimura R A, Callahan M J, Rehder K, Ilstrup D M, TajikJ. Evaluation of intraoperative transesophageal twodimensional echocardiography. Anesthesiology 1987: 66: 64-68. 19. Reichek N, Wilson J, Sutton M S, Plappert T A, Goldberg S, Hirshfeld J W. Noninvasive determination of left ventricular endsystolic stress: validation of the method and clinical application. Circulation 1982: 6 4 99-108. 20. Thys D M, Hillel Z, Konstadt S N, Goldman M E. Intraoperative echocardiography in cardiac anesthesia, 2nd edn. New York: Grune & Stratton, 1983: 255-318. 21. Suga H, Sagawa K. Instantaneouspressure-volume relationships and their ratio in exercised, supported canine left ventricle. Circ Re5 1975: 35: 117-126. 22. Sagawa K. The ventricular pressure-volume diagram revised. Circ Res 1978: 43: 677-687. 23. Sagawa K, Suga H, Shoukas A A, Bakalar K M. End-systolic pressure/volume ratio: a new index of ventricular contractility. Am J Cardiol 1977: 40: 748-753. 24. Baron J-F, Coriat P, Mundler 0,Fauchet M, Bousseau D, Viars P. Left ventricular global and regional function during lumbar epidural anesthesia in patients with and without angina pectoris. Influence of volume loading. Anesthesiology 1987: 66: 621-627. 25. Arndt J 0,Hock A, Stanton-Hicks M, Stuhmeier K-D. Peridural anesthesia and the distribution of blood in supine humans. Anesthesiology 1985: 63: 616-623. 26. Hopf H-B, WeiRbach B, Peters J. High thoracic segmental epidural anesthesia diminishes sympathetic outflow to the legs, de-

spite restriction of sensory block to the upper thorax. Anesthesiology 1990: 73: 882-889. 27. Quinones M A, Mokotoff D M, Noun S, Winters W L, Miller H . Noninvasive quantification of left ventricular wall stress. Validation of method and application to assessment of chronic pressure overload. A m J Cardiol 1990: 45: 782-790. 28. Jorfeldt L, Lofstrom B, Pernow B, Persson B, Wahren J, Widman B. The effect of local anaesthetics on the central circulation and respiration in man and dog. Acta Anaesthesiol Scand 1968: 12: 153-169. 29. Blair M R. Cardiovascular pharmacology of local anaesthetics. Br J Anaesth 1975: 47: 247-252. 30. Ottesen S. The influence of thoracic epidural analgesia on the circulation at rest and during physical exercise in man. Acta Anaesthesiol Scand 1978: 22: 537-547. 31. Sodums M, Badke F, Starling M, Little W, Oâ€™Rourke R. Evaluation of the left ventricular contractile performance utilizing endsystolic pressure-volume relationships in conscious dogs. Circ Res 1984: 54: 731-739. 32. Lee J D, Tajimi T, Widman T F, Ross J Jr. Application of endsystolic pressure-volume and pressure-wall thickness relations in
conscious dogs. 3 A m CON Cardiol 1987: 9: 136-146.
33. Mehmel H C, Stockins B, Ruffman K, Olshausen K, Schuler G , Kubler W. The linearity of the end-systolic pressure-volume relationship in man and its sensitivity for assessment of left ventricular function. Circulation 1981: 63: 1216-1222.
34. Grossman W, Braunwald E, Mann T, McLaurin L P, Green L H. Contractile state of the left ventricle in man as evaluated from end-systolic pressure volume relations. Circulation 1977: 56: 845-852.
35. Borow K M, Neumann A, Wynne J. Sensitivity of end-systolic pressure-dimension and pressure-volume relations to the inotropic state in humans. Circulation 1982: 65: 988494.
36. Crottogini A J, Willshaw P, Barra J G, Armentano R , Cabrera Fisher E I, Pichel R H. Inconsistency of the slope and the volume intercept of the end-systolicpressure volume relationship as individual indexes of inotropic state in conscious dogs: presentation of an index combining both variables. Circulation 1987: 76: 1115-1126.
37. Pagel P S, Kampine J P, Schmeling W T, Warltier D C. Comparison of end-systolic pressure-length relations and preload recruitable stroke work as indices of myocardial contractility in the conscious and anesthetized, chronically instrumented dog. Anesthesiology 1990: 73: 278-290.
38. Currie P J. Transesophageal echocardiography: new window to the heart (editorial). Circulation 1989: 80: 215-217.
Address: Dr. Axel W Goertz Department of Anesthesia University of Ulm Medical Center Steinhovelstr. 9 D-7900 Ulm/Donau Federal Republic of Germany

